BRD6989
CAS No. 642008-81-9
BRD6989 ( BRD-6989;BRD 6989 )
Catalog No. M15440 CAS No. 642008-81-9
A novel potent, selective CDK8 inhibitor with IC50 of 0.5 uM against recombinant Cyclin C/CDK8 complex; displays no activity against several CDKs involved in cell cycle including CDK19 (IC50>30 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 60 | Get Quote |
|
10MG | 88 | Get Quote |
|
25MG | 186 | Get Quote |
|
50MG | 332 | Get Quote |
|
100MG | 494 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBRD6989
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel potent, selective CDK8 inhibitor with IC50 of 0.5 uM against recombinant Cyclin C/CDK8 complex; displays no activity against several CDKs involved in cell cycle including CDK19 (IC50>30 uM).
-
DescriptionA novel potent, selective CDK8 inhibitor with IC50 of 0.5 uM against recombinant Cyclin C/CDK8 complex; displays no activity against several CDKs involved in cell cycle including CDK19 (IC50>30 uM); inhibits IFNγ-induced phosphorylation of STAT1 at Ser 727 site in BMDCs, selectively upregulates IL-10 with EC50 of 1 uM.
-
SynonymsBRD-6989;BRD 6989
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number642008-81-9
-
Formula Weight264.33
-
Molecular FormulaC16H16N4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1CCC2=C(C1)C(=C(C(=N2)N)C#N)C3=CN=CC=C3
-
Chemical Name2-amino-6-methyl-4-(pyridin-3-yl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Johannessen L, et al. Nat Chem Biol. 2017 Oct;13(10):1102-1108.
molnova catalog
related products
-
2-Chloropyrazine
2-Chloropyrazine is used in chemical industry.
-
Palbociclib
A potent and selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM; no inhibition for CDK2A (IC50>5 uM); inhibits MDA-MB453 cells with IC50 of 0.16 uM.
-
BS-181 hydrochloride
BS-181 is a potent, selective CDK7 inhibitor with IC50 of 21 nM.